| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral medication | 15 |
48.4%
|
| 2 | Dapi ring | 0 |
0%
|
| 3 | Injectable long-acting cabotegravir (CABLA) | 16 |
51.6%
|
| Sysmiss | 3426 |